Literature DB >> 10792555

Adverse endothelial function and the insulin resistance syndrome.

J E Tooke1, M M Hannemann.   

Abstract

Type 2 diabetes is characterized by impaired endothelial dependent vasodilatation which may contribute to the high prevalence of vascular disease in such patients. Although hyperglycaemia, dyslipidaemia and hypertension can all independently cause a similar defect, recent data suggest that endothelial dysfunction may be intrinsic to the insulin resistance syndrome that commonly precedes type 2 diabetes. Such abnormalities in endothelial function could represent the impact of subclinical disturbance of metabolism or alternatively the presence of a common cellular defect that influences both nitric oxide bioavailability and insulin mediated glucose disposal. Resolution of this puzzle is likely to lead to important advances in our knowledge and ultimately treatment of vascular disease.

Entities:  

Mesh:

Year:  2000        PMID: 10792555     DOI: 10.1046/j.1365-2796.2000.00671.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  31 in total

1.  Insulin resistance is not necessarily an essential element of metabolic syndrome.

Authors:  Rudruidee Karnchanasorn; Horng-Yi Ou; Lee-Ming Chuang; Ken C Chiu
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 2.  Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.

Authors:  Yogita Rochlani; Naga Venkata Pothineni; Swathi Kovelamudi; Jawahar L Mehta
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-06-22

3.  Six months of aerobic exercise does not improve microvascular function in type 2 diabetes mellitus.

Authors:  A R Middlebrooke; L M Elston; K M Macleod; D M Mawson; C I Ball; A C Shore; J E Tooke
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

4.  Management of the metabolic syndrome in cardiovascular disease.

Authors:  Wai Ping Alicia Chan; Aaron Leonid Sverdlov; John David Horowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

Review 5.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 6.  Impact of metabolic syndrome on cognition and brain: a selected review of the literature.

Authors:  Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

7.  The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.

Authors:  A Rafnsson; F Böhm; M Settergren; A Gonon; K Brismar; J Pernow
Journal:  Diabetologia       Date:  2011-12-27       Impact factor: 10.122

8.  The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.

Authors:  J E Tooke; L M Elston; K M Gooding; C I Ball; D M Mawson; J Piper; R Sriraman; R Urquhart; A C Shore
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

9.  Metabolic syndrome is associated with learning and recall impairment in middle age.

Authors:  Jason J Hassenstab; Victoria Sweat; Hannah Bruehl; Antonio Convit
Journal:  Dement Geriatr Cogn Disord       Date:  2010-04-24       Impact factor: 2.959

Review 10.  Adipokines, inflammation, and the endothelium in diabetes.

Authors:  Waleed Aldhahi; Osama Hamdy
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.